The Spanish IT multinational company Intel and the Barcelona Supercomputing Center will create a joint research and development lab to calculate speeds on the exaFLOP scale, which are a thousand times quicker than the current fastest computers...
The last ‘SCImago Institutions Ranking’ classified the 3,000 best research institutions in the world. Harvard University tops the ranking, but the Catalan institute, is ranked second in Spain and among the best European research centres....
For the first time in the world, a foetus having the spina bifida congenital disorder went through a new intra-uterus surgery technique. A medical team from Barcelona’s Vall d’Hebron Hospital operated on the foetus in its 24th week by...
The vaccine MVA-B against HIV gets a 90% immune response in its first test with humans. In addition, after a year, the vaccine proves to still be effective in 85% of the individuals. The vaccine is still a prototype but it shows a promising...
Between 2007 and 2010, Catalan research centres and private companies participated in a total of 1,047 projects funded by the Seventh Framework Programmes for Research and Technological Development of the European Union. In total, Catalan...
The study by the Bellvitge Biomedical Research Institute has managed to demonstrate that a molecule similar to glucose can cause the death of cancerous cells. The research would enable to shortly develop treatments for the alveolar...
"This could mean a breakthrough in the fight against cancer," said the head of the study Juan Angel Recio from Barcelona-based Vall d’Hebron Research Institute.
The research results were published on the website of the prestigious journal 'Nature Chemistry' and will appear in the print edition as well. The Universitat de Girona is particularly strong in research related to water. The study opens a new...
Catalan researchers participated in an international study which analysed of more than 20,000 women from various countries. They have found that using intrauterine contraceptive devices (IUD) reduces the risk to suffer cervical cancer by half.
